Stock-Based Compensation | 3 Months Ended |
Nov. 01, 2014 |
Stock-Based Compensation [Abstract] | ' |
Stock-Based Compensation | ' |
5. Stock-Based Compensation |
|
The compensation costs that have been charged against income for the thirteen and thirty-nine weeks ended November 1, 2014 and November 2, 2013 were as follows (in thousands): |
|
| | Thirteen Weeks Ended | | | Thirty-Nine Weeks Ended | |
| | 1-Nov-14 | | | 2-Nov-13 | | | 1-Nov-14 | | | 2-Nov-13 | |
Stock-based compensation expense by type: | | | | | | | | | | | | |
Stock options | | $ | 19 | | | $ | 17 | | | $ | 449 | | | $ | 340 | |
Restricted stock unit awards, including performance-based | | | 122 | | | | 1,321 | | | | 3,059 | | | | 4,207 | |
Employee stock purchases | | | 25 | | | | 26 | | | | 81 | | | | 84 | |
Director deferred compensation | | | 18 | | | | 34 | | | | 52 | | | | 96 | |
Total stock-based compensation expense | | | 184 | | | | 1,398 | | | | 3,641 | | | | 4,727 | |
Income tax benefit recognized | | | 60 | | | | 516 | | | | 1,342 | | | | 1,745 | |
Stock-based compensation expense, net of income tax | | $ | 124 | | | $ | 882 | | | $ | 2,299 | | | $ | 2,982 | |
|
In the thirteen and thirty-nine weeks ended November 1, 2014 and November 2, 2013, we granted the following equity awards: |
|
| | Thirteen Weeks Ended | | | Thirty-Nine Weeks Ended | |
| | 1-Nov-14 | | | 2-Nov-13 | | | 1-Nov-14 | | | 2-Nov-13 | |
Stock options | | | 1,244 | | | | 810 | | | | 19,219 | | | | 19,251 | |
Restricted stock unit awards | | | - | | | | - | | | | 63,399 | | | | 62,625 | |
Performance-based restricted stock unit awards | | | - | | | | - | | | | 25,300 | | | | 36,700 | |
Deferred stock units | | | 411 | | | | 601 | | | | 10,740 | | | | 8,076 | |
|
Under the 2012 Non-Employee Director Equity Plan (2012 Plan), a total of 1,759 and 2,312 shares of our common stock were awarded during the thirty-nine weeks ended November 1, 2014 and November 2, 2013, respectively, as part of the annual equity award to directors in the first quarter. In addition, under our employee stock purchase plan, our employees purchased 2,115 and 1,994 shares of our common stock during the thirteen weeks ended November 1, 2014 and November 2, 2013, respectively, and 6,796 and 6,860 shares of our common stock during the thirty-nine weeks ended November 1, 2014 and November 2, 2013, respectively. |
|
The weighted-average grant date fair value of stock options granted during the thirteen and thirty-nine weeks ended November 1, 2014 was $15.36 and $23.38 per share, respectively. The weighted-average grant date fair value of shares of stock purchased through our employee stock purchase plan was $9.50 and $11.16, and the weighted-average price paid by our employees for shares of our common stock was $36.24 and $42.35 during the thirteen and thirty-nine weeks ended November 1, 2014, respectively. |
|
The weighted-average grant date fair value of stock options granted during the thirteen and thirty-nine weeks ended November 2, 2013 was $21.51 and $17.68 per share, respectively. The weighted-average grant date fair value of shares of stock purchased through our employee stock purchase plan was $12.94 and $12.34, and the weighted-average price paid by our employees for shares of our common stock was $47.40 and $46.03 during the thirteen and thirty-nine weeks ended November 2, 2013, respectively. |
|
At November 1, 2014, the total compensation costs, related to nonvested restricted stock unit awards not yet recognized was $8.6 million and the weighted-average period over which such awards are expected to be recognized was 2.4 years. There are no future compensation costs related to nonvested stock options to be recognized at November 1, 2014. |